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Gi; Ca 2ϩ mobilization; store-operated Ca 2ϩ channel; bone marrowderived cultured mast cells MAST CELL IS GENERALLY REGARDED as a key effector cell in parasite infection and anaphylactic response. However, accumulating evidence suggests that mast cell plays critical roles in much broader ranges of immune responses, such as peripheral tolerance and bacterial infection (19, 20) . Migration and adhesion play critical roles in regulation of mast cell functions in tissues, in particular under emergency conditions. Previous studies have indicated that mast cells are often accumulated in inflamed tissues, such as in the airways in atopic asthma and synovial tissues in rheumatoid arthritis.
Prostaglandin E 2 (PGE 2 ) is one of the major eicosanoids produced during inflammatory responses. Although mast cells are not the major source of PGE 2 , a wide variety of cells that can generate PGE 2 are found in close proximity of mast cells, such as smooth muscle cells, respiratory epithelial cell, fibroblasts, and macrophages (2, 4, 9, 13) . Based on these findings, we hypothesized that PGE 2 can affect migration and adhesion of tissue mast cells by acting on the specific receptors. Using a mouse mastocytoma, P-815, our laboratory previously demonstrated that PGE 2 induces the adhesion to the Arg-Gly-Asp (RGD)-enriched matrix through elevation of cAMP levels, which results from cooperation between two PGE 2 receptor subtypes: EP3 and EP4 (7) . EP3 subtype is known to be coupled to multiple G proteins, such as G i , G s , and G 12 (17, 23) . In P-815 cells, augmentation of the EP4-mediated cAMP generation by the EP3 subtype was suppressed by treatment with pertussis toxin (PTX), indicating that the EP3 subtype is coupled to G i and liberation of ␤␥-subunit may be involved in augmented cAMP generation. Very recently, Weller et al. demonstrated that PGE 2 can function as a chemotactic factor of mast cells by acting on the EP3 subtype (28) . Although the EP4 subtype is expressed in bone marrow-derived cultured mast cells (BMMCs), PGE 2 -induced chemotaxis is mediated solely by the EP3 subtype; PGE 2 -induced chemotactic responses were suppressed by treatment with PTX and mimicked by an EP1/EP3 agonist. Since accumulating evidence suggests that the dominant receptor that is responsible for PGE 2 -induced responses in mast cells depends on the species and tissue localization (3), it is possible that the EP4-independent pathway is involved in PGE 2 -induced adhesion of BMMCs. We here characterized the PGE 2 -induced adhesion of BMMCs and peritoneal mast cells to the RGD-enriched matrix and found that the EP3 subtype plays a dominant role in adhesion of BMMCs and peritoneal cells.
MATERIALS AND METHODS
Animals. Specific-pathogen-free, 6-wk-old female C57BL/6 mice were obtained from Japan SLC (Hamamatsu, Japan). The Ptger3 Ϫ/Ϫ mice (25) were back-crossed for at least eight generations to the C57BL/6 background. This study was approved by the Committee on Animal Experiments of Mukogawa Women's University and conformed with the Guiding Principles in the Care and Use of Animals of the American Physiological Society.
Materials. Sulprostone was a generous gift from Dr. M. P. L. Caton of Rhone-Poulenc. ONO-AE-248 and ONO-AE1-437 were gener-ously supplied by ONO Pharmaceuticals (Osaka, Japan). ProNectin F (ProF) and ProNectin L (ProL) were generously supplied by Sanyo Chemical Industries (Kyoto, Japan). The following materials were obtained from the sources indicated: GRGDS peptide from PEPTIDE Institute (Osaka, Japan); Cellmatrix (type I-P collagen) from Nitta Gelatin (Osaka, Japan); Histodenz, bovine serum albumin (BSA), thapsigargin, and an anti-dinitrophenyl IgE (clone SPE-7) from Sigma-Aldrich (St. Louis, MO); PTX from Seikagaku (Tokyo, Japan); PGE2 from Cayman Chemical (Ann Arbor, MI); 12-O-tetradecanoylphorbol 13-acetate (TPA) and Gö6976 from Calbiochem (San Diego, CA); SKF 96365 from TOCRIS (Bristol, UK); thrombin from bovine plasma and fura-2 AM from NACALAI TESQUE, (Kyoto, Japan); U-73343 and U-73122 from BIOMOL (Exeter, UK); RNeasy Mini Kit from QIAGEN (Valencia, CA); Moloney murine leukemia virus (MMLV) reverse transcriptase from Invitrogen (Carlsbad, CA); and Taq DNA polymerase from TOYOBO (Osaka, Japan). All other chemicals were commercial products of reagent grade.
Preparation of BMMCs. BMMCs were prepared as described previously with a minor modification (24) . Bone marrow cells were cultured in RPMI-1640 containing 10% heat-inactivated FBS, 50 M ␤-mercaptoethanol, and 0.1 mM nonessential amino acids at 37°C in a fully humidified 5% CO2 atmosphere for 4 -5 wk in the presence of 10 ng/ml IL-3 instead of WEHI-3-conditioned medium. Greater than 95% of the viable cells were confirmed to be immature mast cells, as assessed by staining with acidic toluidine blue (pH 2.5).
Measurement of cell adhesion. Twelve-well culture plates were coated with 10 g/ml ProF, 10 g/ml ProL, 0.3 mg/ml Cellmatrix, or 3% BSA. BMMCs were seeded on the well at a density of 1 ϫ concentration was measured with fura-2 AM, as previously described (24) . Fluorescent intensities were measured, at an excitation wavelength of 340 or 380 nm and an emission wavelength of 510 nm, with a fluorescence spectrometer (CAF-110, Jasco, Tokyo, Japan). Purification of peritoneal mast cells. Mouse peritoneal cells were recovered with Tyrode-HEPES buffer (130 mM NaCl, 5 mM KCl, 1.4 mM CaCl2, 1 mM MgCl2, 5.6 mM glucose, 10 mM HEPES-NaOH, pH 7.3) containing 0.1% gelatin (THG buffer) and centrifuged for 5 min at 800 g. The peritoneal cells were suspended in THG buffer, layered onto gradient solution containing 25% (wt/vol) Histodenz, and centrifuged for 15 min at 500 g. The resultant cell pellet was twice washed with PBS to obtain purified peritoneal mast cells (Ͼ90% purity, confirmed by Alcian blue/Safranin-O staining). In the case of purification of rat peritoneal mast cells, 0.05% gelatin and 22.5% (wt/vol) Histodenz were alternatively used, and density gradient separation was performed at 45 g.
RT-PCR. Total RNAs were isolated from BMMCs or the purified peritoneal mast cells using RNeasy Mini Kit, according to the manufacturer's instructions. Total RNAs were reverse transcribed using MMLV reverse transcriptase and amplified by PCR using a primer offset for each PGE receptor subtypes: EP1 (1,014 bp), 5Ј-ACC CTG CAT CCT GAG CAG CAC TGG CCC TCT-3Ј (forward) and 5Ј-CGA TGG CCA ACA CCA CCA ACA CCA GCA GGG-3Ј (reverse); EP2 (604 bp), 5Ј-TTC ATA TTC AAG AAA CCA GAC CCT GGT GGC-3Ј (forward) and 5Ј-AGG GAA GAG GTT TCA TCC ATG TAG GCA AAG-3Ј (reverse); EP3 (608 bp), 5Ј-ATC CTC GTG TAC CTG TCA CAG CGA CGC TGG-3Ј (forward) and 5Ј TGC TCA ACC GAC ATC TGA TTG AAG ATC ATT-3Ј (reverse); EP4 (601 bp), 5Ј-GAC TGG ACC ACC AAC GTA ACG GCC TAC
GCC-3Ј (forward) and 5Ј-ATG TCC TCC GAC TCT CTG AGC AGT GCT GGG-3Ј (reverse).
Measurement of peritoneal mast cell adhesion. Eight-well chamber slides (AGC Techno glass, Funahashi, Japan) were coated with 10 g/ml ProF or 3% BSA. Peritoneal cells were collected in Tyrode-HEPES buffer containing 0.1% BSA and resuspended in RPMI-1640 medium containing 10% heat-inactivated FBS. Peritoneal cells were seeded on the chamber in the presence of 10 M indomethacin at a density of 1 ϫ 10 5 cells ⅐ 0.5 ml Ϫ1 ⅐ well Ϫ1 (mouse peritoneal cells) or of 1 ϫ 10 4 cells ⅐ 0.5 ml Ϫ1 ⅐ well Ϫ1 (rat peritoneal mast cells). The cells were incubated for 30 min at 37°C before stimulation. The adherent cells were fixed by 100 mM sodium phosphate, pH 7.4, containing 3% sucrose, 2% paraformaldehyde, and 0.1% glutaraldehyde, and stained with the acidic toluidine blue. Percentages of mast cells in the total peritoneal cells were determined based on the count of the cells stained with 2% Giemsa solution.
RESULTS

PGE 2 -induced adhesion of BMMCs to ProF.
Our laboratory previously reported the PGE 2 -induced adhesion of P-815 cells to an RGD-enriched matrix, ProF (7) . In the present study, we investigated the effects of PGE 2 on adhesion activity of BMMCs. PGE 2 significantly augmented the adhesion of BMMCs to ProF or ProL, but not to type I collagen or BSA (Fig. 1A) . The stimulated adhesion to ProF was suppressed in the presence of the GRGDS peptide (Fig. 1B) , indicating that BMMCs adhere to ProF via the RGD sequence as well as P-815 cells did. The PGE 2 -induced adhesion to ProF was a saturable and concentration-dependent response (Fig. 1C) .
EP3 subtype is essential for PGE 2 -induced adhesion and Ca 2ϩ mobilization. We then investigated the time course of adhesion of BMMCs to ProF. PGE 2 -induced adhesion was transient, and the adhesion level returned to the base level 6 h after the stimulation (Fig. 2A) . PGE 2 -induced adhesion was well mimicked by sulprostone (EP1 and EP3 agonist) and ONO-AE-248 (EP3 agonist), but not by ONO-AE-1-437 (EP4 agonist), indicating the involvement of the EP3 subtype. We, therefore, investigated the adhesion using BMMCs derived from the Ptger3 Ϫ/Ϫ mice. PGE 2 -induced adhesion was abolished in the Ptger3 Ϫ/Ϫ BMMCs (Fig. 2B ). No significant difference between the Ptger3 ϩ/ϩ and Ptger3 Ϫ/Ϫ BMMCs was found in adhesion to ProF stimulated with TPA or monomeric IgE (16) , indicating that the machinery required for the adhesion to ProF is not impaired in the Ptger3 Ϫ/Ϫ BMMCs (Fig. 2,  C and D) . BMMCs from the Ptger3 ϩ/ϩ mice were found to express both the EP3 and EP4 subtype mRNAs, as previously reported (Fig. 2E) .
G i -mediated Ca 2ϩ mobilization is one of the signaling events downstream of the EP3 subtype (10) . PGE 2 induced a drastic Ca 2ϩ mobilization in the Ptger3 ϩ/ϩ BMMCs, followed by a sustained phase with a moderate cytosolic Ca 2ϩ level (Fig. 3) . Similar responses were observed in the Ptger3
BMMCs stimulated with sulprostone and ONO-AE-248, but not with ONO-AE1-437. In the Ptger3 Ϫ/Ϫ BMMCs, PGE 2 -induced Ca 2ϩ mobilization was drastically attenuated, and no EP agonists tested could induce Ca 2ϩ mobilization ( Fig. 3 and data not shown). Treatment with thrombin (Fig. 3) or monomeric IgE (data not shown) induced similar levels of Ca 2ϩ mobilization responses in the Ptger3 ϩ/ϩ and Ptger3 Ϫ/Ϫ BMMCs. In contrast to the drastic elevation of cAMP levels in P-815 cells stimulated with PGE 2 , PGE 2 failed to induce cAMP elevation in BMMCs (data not shown). 
Characterization of EP3-mediated adhesion and Ca
2ϩ mobilization in BMMCs. Since the EP3 subtype is known to be coupled to multiple trimeric G proteins, we then investigated the signaling pathway downstream of the EP3 subtype. PGE 2 -induced adhesion and Ca 2ϩ mobilization in BMMCs were strikingly suppressed by pretreatment with PTX, indicating the dominant role of G i /G o (Fig. 4, A and B) . Pretreatment of BMMCs with a specific inhibitor of phospholipase C, which is known to be activated upon G ␤␥ liberation from trimeric G i complex, abolished the adhesion responses and Ca 2ϩ mobilization induced by PGE 2 (Fig. 4, C and D) . It remains unknown which kinds of Ca 2ϩ channels are involved in the Ca 2ϩ influx induced by the EP3 subtype. We found that SKF 96365, a specific inhibitor of store-operated Ca 2ϩ channels, has a potential to block the PGE 2 -induced Ca 2ϩ mobilization and adhesion (Fig. 4, E and F) . These results collectively indicate that the EP3 subtype is coupled to G i and induces Ca 2ϩ mobilization, which is maintained by persistent activation of the store-operated Ca 2ϩ channels.
Deficiency in PGE 2 -induced adhesion in peritoneal mast cells of the Ptger3
Ϫ/Ϫ mice. Several functions specific to mature mast cells, such as cationic secretagogue-induced degranulation, are not reproduced in BMMCs, even though BMMCs can well mimic the functions of immature mast cells. It is of great interest to determine whether mature mast cells utilize the EP3 or EP4 subtype for adhesion. We then investigated the PGE 2 -induced adhesion to ProF in peritoneal mast cells, which are regarded as typical connective tissue-type mast cells. Pu- rified peritoneal mast cells were found to exclusively express the EP3 subtype by RT-PCR analyses (Fig. 5A) . PGE 2 -induced adhesion of peritoneal mast cells to ProF was concentration dependent, and the EC 50 value of this response was similar to that in BMMCs (Figs. 5B and 1C ). In the Ptger3 Ϫ/Ϫ peritoneal cells, PGE 2 -induced adhesion of mast cells was completely abolished, whereas a similar level of adhesion was observed in the presence of TPA compared with the Ptger3 ϩ/ϩ peritoneal cells (Fig. 5, C-E (Fig. 5F ). In addition, the GRGDS peptide blocked the PGE 2 -induced adhesion of the peritoneal mast cells (Fig. 5G) . These results indicate that the EP3 subtype mediates the PGE 2 -induced adhesion of mouse peritoneal mast cells in a similar manner to that of BMMCs.
EP3-mediated Ca 2ϩ mobilization and adhesion of rat peritoneal mast cells. Although the inhibitory effects of SKF 36965 on the adhesion of peritoneal mast cells imply the requirement of PGE 2 -induced Ca 2ϩ influx, it was found to be quite difficult to determine the cytosolic Ca 2ϩ levels using purified mouse peritoneal mast cells in a reproducible manner. We then used rat peritoneal mast cells to investigate PGE 2 -induced signal transduction, since rat peritoneal mast cells can be readily purified and have been used as the good model for connective tissue-type mast cells. The adhesion of the peritoneal mast cells to ProF was significantly augmented by PGE 2 or the EP3 agonist, but not by the EP4 agonist (Fig. 6A) . The PGE 2 -or EP3 agonist-induced adhesion was abolished in the presence of the GRGDS peptide or SKF 36965, as well as in the mouse peritoneal mast cells (Fig. 6A) . PGE 2 and the EP3 agonist were found to induce Ca 2ϩ mobilization in the rat peritoneal mast cells, which was completely suppressed by SKF 36965 (Fig. 6B) . These results suggest that PGE 2 can evoke Ca 2ϩ mobilization and stimulate the adhesion to ProF in the rat peritoneal mast cells, which can be mimicked by the EP3 agonist.
DISCUSSION
In contrast to the adhesion through cAMP elevation by cooperation between the EP3 and EP4 subtypes in P-815 cells (7), the EP3 subtype was found to play an essential role in PGE 2 -induced adhesion of BMMCs and peritoneal mast cells through Ca 2ϩ mobilization. The signaling pathways utilized in Fig. 5 . Detection of PGE2 receptor subtype mRNAs and PGE2-induced adhesion of mouse peritoneal mast cells to ProF. A: total RNA from mouse purified peritoneal mast cells (pMC) was isolated and subjected to RT-PCR analyses, and the amplified PCR products for the EP1, EP2, EP3, and EP4 subtype were detected. Total RNAs from various tissues were used as positive controls (P): kidney for the EP1, uterus for the EP2, brain for the EP3, and intestine for the EP4 subtype. PCR was performed without RNA as a negative control (N). mast cells stimulated by PGE 2 can be classified into two types: one is mediated through cAMP elevation by the G s -coupled subtype, such as EP2 and EP4; and the other is through Ca 2ϩ mobilization by the G i -coupled subtype, EP3. PGE 2 -induced cAMP elevation suppressed the histamine release upon antigen stimulation in rat peritoneal and human lung mast cells (12, 22) and resulted in release of vascular endothelial growth factor in human cord blood-derived cultured mast cells through activation of the EP2 subtype (1) . In these kinds of mast cells, cAMP elevation plays a key role in the PGE 2 -induced signal transduction. On the other hand, PGE 2 or an EP1/EP3 agonist, sulprostone, was reported to stimulate IL-6 release and potentiate degranulation upon antigen stimulation in a mouse IL-3-dependent mast cell line, MC9 (6). Nguyen et al. (21) demonstrated PGE 2 -induced Ca 2ϩ mobilization and PGE 1 -mediated augmentation of antigen-induced degranulation in BMMCs, both of which are abolished in BMMCs derived from the EP3-deficient mice. They also showed that PGE 2 failed to enhance cAMP formation in BMMCs, although the expression of the EP4 subtype was detected. These results indicate that the action of PGE 2 is mediated exclusively by the EP3 subtype in BMMCs and MC9 cells. Considering the characteristics of mast cells involved in these PGE 2 -induced responses together, degrees of maturation, species difference, and/or malignant conversion may determine the available EP subtypes and their roles in the signal transduction. BMMCs were found to express both the EP3 and EP4 subtype (21, 28 , and this study), which is similar in the expression pattern to P-815 cells. Further studies are required to clarify how the signaling pathway downstream of the EP3 subtype is differentially regulated, since the EP3 subtype augments EP4-mediated cAMP production in P-815 cells but induces Ca 2ϩ mobilization in BMMCs and rat peritoneal mast cells.
Our laboratory characterized in detail the EP3-mediated Ca 2ϩ mobilization in the present study. We found that PGE 2 -induced Ca 2ϩ increase consists mainly of Ca 2ϩ influx, which is suppressed by a specific inhibitor for store-operated Ca 2ϩ channels, SKF 96365. Since the adhesion of BMMCs and rat peritoneal mast cells was completely suppressed in the presence of the inhibitors that suppressed Ca 2ϩ mobilization induced by PGE 2 , it is likely that G i -mediated Ca 2ϩ influx plays a pivotal role downstream of the EP3 subtype, at least in the adhesion response. PTX-sensitive adhesion of BMMCs to fibronectin was also reported with the other mediators, such as thrombin and 5-hydroxytryptamine (15, 26) . Thrombin was reported to induce the adhesion of BMMCs by acting on protease-activated receptor-1, which was accompanied by degranulation and IL-6 production (26). Although the author did not measure the cytosolic Ca 2ϩ levels, these responses should be mediated by Ca 2ϩ mobilization, as well as in the present study.
It remained unknown which subtypes of the EP receptors are expressed in mature tissue mast cells. We demonstrated that the EP3 subtype is the only detectable EP subtype in mouse peritoneal mast cells and that PGE 2 -induced adhesion is abolished in the Ptger3 Ϫ/Ϫ mast cells. Kunikata et al. (14) demonstrated that antigen-induced histamine release is significantly suppressed by PGE 2 or ONO-AE-248 (EP3 agonist) in lung tissues, and such suppressive effect was abolished in the Ptger3 Ϫ/Ϫ lung tissues. Since it remains controversial whether the EP3 subtype suppresses or potentiates degranulation upon antigen stimulation (5, 6, 14, 21) , much attention should be paid to the heterogeneity of tissue mast cells. In regard to mouse peritoneal mast cells, we observed no detectable degranulation in the presence of PGE 2 , whereas high concentrations of TPA induced significant levels of degranulation (data not shown).
Recent studies demonstrated that mast cells can undergo chemotaxis in response to various chemoattractants, such as histamine, 5-hydroxytryptamine, PGE 2 , leukotriene B 4 , and sphingosine-1-phosphate (8, 11, 15, 27, 28) . These results indicate that mast cells have a tendency to accumulate at the inflamed site that is characterized by production of these chemoattractants. We noticed that the adhesion of BMMCs in response to PGE 2 is rapid and transient. Process of mast cell activation can be generally classified into two phases: mast cells release histamine and neutral proteases through degranulation and generate a series of lipid mediators in the immediate phase, whereas they produce chemokines and cytokines in the late phase (18) . Considering this time course, it is likely that PGE 2 -induced transient adhesion to fibronectin restricts chemotaxis of mast cells during the immediate phase. PGE 2 may regulate the localization of tissue mast cells under inflammatory conditions and potentiate the impact of proinflammatory mediators generated by mast cells.
We conclude that the EP3 subtype is essential for PGE 2 -induced adhesion of mouse BMMCs and rat peritoneal mast cells through Ca 2ϩ mobilization. It is likely that EP3-mediated Ca 2ϩ mobilization is mediated by the G i -phospholipase C axis. This pathway may play a critical role in regulation of mast cell adhesion under inflammatory conditions.
